Vlatko Čančar's Knee and the Medical Verdict No European Club Bothers to Read

The news arrived from Burgos on an unremarkable day. Vlatko Čančar requires meniscus surgery and will miss several months. San Pablo Burgos had just signed him in the summer, betting on a name that spent six seasons with the Denver Nuggets. They have not received a single competitive minute. What they received was a medical notice, a hole in the roster, and a salary already paid. Read this as a routine injury note and you will miss the point. The meniscus operation is only the fourth red mark on an already crowded page. The real story sits in a data point nobody bothers to bold: 21. That is the total number of games Čančar has played across all competitions since October 2026 — an availability profile lower than a benchwarmer's. The pattern is not random. A fracture in 2026. An ACL tear in 2026. Recurrent knee problems. And now a meniscus requiring surgery, in the same anatomical zone. Armani Milan signed him for EuroLeague and got two games. Burgos repeated the gamble at EuroCup level and did not even reach game one. The dominant industry story here is what I call the "NBA pedigree discount" — the belief that six years in Denver confer technical qualities domestic players lack. Perhaps. But the price of that belief is a medical file nobody reads closely. This is not about shooting splits; it is about presence. I can be wrong, and I say so plainly. If his knee holds until April they will call it a bargain, not a mispricing.